OVERVIEW _| _DETAILED AGENDA _|_DOWNLOAD BROCHURE _|_SPEAKING FACULTY _|_ JOIN OUR FACULTY _|_ ATTENDEES _|_CONFERENCE SPONSORS _|_ MARKETING PARTNERS _|_ NEWS _|_ VENUE _|_ REQUEST BROCHURE_|_ PRICING _|_ REGISTER NOW!


DETAILED AGENDA:
To review professional background of each member of our faculty, Click Here.

Sunday, May 19, 2013

9:00am – 1:00pm
Exhibitor Set-up
(Hall CLOSED, NO EXHIBITOR SET UP AFTER 1:00pm on Sunday, May 19, 2013)


11:00am – 6:00pm
Conference Registration Open


2:00 – 7:00pm
Exhibit Hall Opens
(Light snacks served in Exhibit Hall beginning at 2:00pm)


12:00pm
CONCURRENT WORKSHOPS & SESSIONS
Workshop Track A:
Workshop Track B:

12:00 – 1:55pm
(WA01) Evaluating and Negotiating Clinical Research Contracts

WORKSHOP LEADER:

Penny S. Smith, Attorney,
Penny Smith Life Science Law Group, LLC

WORKSHOP PRESENTER(S):
Peter Sullivan, CIC,VP and Principal,
Sullivan Group

 

12:00 – 12:55pm
(WB01) Working with Small Sponsors and CROs

WORKSHOP LEADER:

Elizabeth Robinson, RN, RQAP-GCP, RAC-US, Executive Director of Compliance and Quality,
Advanced Clinical LLC

WORKSHOP PRESENTER(S):
Michelle Hylan, Principal Consultant,
Halloran Consulting Group
Katie McCarthy, Principal Consultant,
Halloran Consulting Group

1:00 – 1:55pm
(WB02) Simplifying Protocol Designs and Determining Protocol Feasibility

WORKSHOP LEADER:

Christian Burns, Director of Clinical Operations and Marketing, ClinEdge, LLC

WORKSHOP PRESENTER(S):
Salah Benyamina, M.D., Lead Medical Operation Oncology, Sanofi
Chris Frega, Sr. Director & Head of Global Feasibility, Quintiles

2:00 – 7:00pm
Exhibit Hall OPEN


2:00 – 3:00pm
REFRESHMENTS AND NETWORKING BREAK (In Exhibit Hall)


Special Program on
Successful Site Leadership & Capabilities
Workshop Track A:
Workshop Track B:

3:00 – 3:55pm
(SP03) Transformation and Consolidation

  • Disruptive Practices and Technologies Transforming Investigative Sites
  • Anticipating Consolidation among Global Site Networks
MODERATOR:

Abraham Gutman, President & CEO, AG Mednet, Inc.

PRESENTER(S):
(SP03b) Anticipating Consolidation among
Global Site Networks

Dr. Christophe Berthoux, CEO,
Synexus Clinical Research, Ltd.

David A. Evans, Managing Director, Accenture


4:00 – 4:55pm
(SP02) Strategic Planning

  • Successful Growth Strategies for Investigative Sites
  • Positioning Site Strengths and Performance to Maximize Grant Leads
  • Establishing Competitive Advantage in Sponsor and CRO Relationships
MODERATOR:

Mack D. Rubley, Ph.D., Director, Business Development,
Boston Biomedical Associates

PRESENTER(S):
(SP02a) Successful Growth Strategies for Investigative Sites

Mark Lacy, CEO and Co-Founder,
Benchmark Research

(SP02b) Positioning Site Strengths and Performance to Maximize Grant Leads

Nicole Osborn, CEO and Owner,
Meridian Clinical Research, LLC

(SP02c) Establishing Competitive Advantage in CRO Relationships

Peter Fredette, Associate Director, Integrated Site Services and Alliance Manager, U.S. Prime Sites, Quintiles


5:00 – 5:55pm
(SP01) Landscape Threats and Opportunities for Investigative Sites

PRESENTER(S):

Ken Getz, Founder and Owner,
CenterWatch

3:00 – 3:55pm
(WA02) Evaluating Data, Financial, and Resource Management Systems

WORKSHOP LEADER:

Sergio Armani, Director, Global Business Development, Clinical Conductor, Europe Team Leader, Bio-Optronics

WORKSHOP PRESENTER(S):

Rick Greenfield, Owner,
RealTime Software Solutions, LLC

Christine Pierre, Founder and President, Society for Clinical Research Sites


4:00 – 5:55pm
(WA03) Site Study Budgets: Determining Fair and Equitable Study Budgets &
Preparing ‘True’ Cost Budgets

WORKSHOP LEADER:

Terry Stubbs, President and CEO,
ActivMed Practices & Research

WORKSHOP PRESENTER(S):

Deena Bernstein,
Director of Clinical Research,
Sheridan Clinical Research

Victor Lucariello, Jr., Associate Manager, Investigator Grants, Clinical Site Contracts, Celgene Corporation

3:00 – 3:55pm
(WB03) Inspection Readiness and SOPs and Responding to Regulatory Agency
Requests
Preparing for Audits and Inspections & Responding to Regulatory Agency Requests

WORKSHOP LEADER:

Elizabeth Robinson, RN, RQAP-GCP, RAC-US, Executive Director of Compliance and Quality,
Advanced Clinical LLC

WORKSHOP PRESENTER(S):

Liz Bodi, Senior Consultant,
Halloran Consulting Group

Denise Lacey, Principal Consultant, Halloran Consulting Group


4:00 – 4:55pm
(WB04) Establishing a Patient-centric Clinical Trial

WORKSHOP PRESENTER(S):

Marisa Co, PharmD, MBA, President, National Research Institute

Nicki Norris, CEO,
Symphony Clinical Research

Sunil J. Wimalawansa, M.D., Ph.D, D.Sc., Professor, Cardio Metabolic Institute of New Jersey


5:00 – 5:55pm
(WB05) Getting the Most out of Feasibility Assessments, Pre-study Visits, and Investigator Meetings

WORKSHOP LEADER:

Christian Burns, Director of Clinical Operations and Marketing, ClinEdge, LLC

WORKSHOP PRESENTER(S):

Eileen Daniel, Director,
Clinical and Data Operations,
Endo Pharmaceuticals

James Denmark, CEO,
myClin


6:00 – 7:00pm
Welcome to Boston
– Evening Networking Reception (in Exhibit Hall)


7:00
Exhibit Hall CLOSED

Monday, May 20, 2013

7:30 – 8:30am
Exhibit Hall OPEN
Conference Registration & Continental Breakfast (in Exhibit Hall)


8:30 – 9:45am
Exhibit Hall CLOSED (for conference sessions)


8:30 – 8:45am
(MP01) Welcome to Boston and Conference Overview

Joan A. Chambers, Conference Chair
Chief Operating Officer, CenterWatch

8:45 – 9:45am
(MP02) Drug Development Landscape Trends: Trends in Drug Pipelines, Drug Development Practices, and Partnerships

KEYNOTE PRESENTER:
Ken Getz, Founder and Owner, CenterWatch
Director, Sponsored Research Programs, Tufts CSDD
Chairman, CISCRP

(MP02a) Drug Pipelines, Development Practices, and Partnerships: A Moderated Panel Discussion

MODERATOR:  

Ken Getz, Founder and Owner, CenterWatch
Director, Sponsored Research Programs, Tufts CSDD
Chairman, CISCRP

 
PANELISTS:  

Paul Biondi, SVP R&D Operations,
Bristol Myers Squibb

Jennifer Byrne, President & CEO,
PMG Research, Inc.

Andy Lee, Deputy Head of Clinical Sciences and Operations, Sanofi

Warren Myers,
VP Global Strategic Outsourcing,
Takeda Pharmaceuticals

Christine Pierre, Founder and President,
Society for Clinical Research Sites

Beat Widler, Ph.D., Managing Partner,
Widler & Scheimann AG


9:45am – 12:00pm
Exhibit Hall OPEN


SPONSORED BY:

9:45 – 10:15am
MID-MORNING NETWORKING BREAK (In Exhibit Hall)


10:15am
CONCURRENT TRACKS BEGIN: Choose from Tracks A, B, or C

Track A:
Innovative Strategies:
Leadership, Innovations and Global Solutions
Track B:
Operating Practices & Efficiencies:
Real-world case studies and Practical
How-tos for Sponsors, Sites, CROs and everyone in between
Track C:
Effective Oversight & Regulation:
FDA, Medicare, Medicaid, Subject Protection and more
(TA01) Track Moderator:

Amy Fontaine, Sr. Manager, CenterWatch
(TB01) Track Moderator:

Darlene Panzitta, President and
Founder, DSP Clinical Research
(TC01) Track Moderator:

Joan A. Chambers, Chief
Operating Officer, CenterWatch

10:15 –11:15am
(TA02) Best practices for Establishing Preferred, Integrated Relationships with CROs

MODERATOR:

Mack D. Rubley,Ph.D.,
Director, Business Development,
Boston Biomedical
Associates

PRESENTER(S):

Peter Fredette, Associate Director, Integrated Site Services and Alliance Manager, U.S. Prime Sites, Quintiles


11:15am – 12:15pm
(TA03) Establishing Preferred Relationships with Investigative Sites

MODERATOR:

Christian Burns, Director of Clinical Operations and Marketing, ClinEdge, LLC

PRESENTER(S):

Deirdre Albertson,
Sr. Director, Clinical Research, inVentiv Clinical

Andrew Kimball, Director, Research & Development, Benchmark Research

10:15 – 11:15am
(TB02) Assessing and Managing Key Cost
Drivers in Clinical Research

MODERATOR:

Jan Cuypers, Associate Director, Finance and Accounting, Millennium Pharmaceuticals

PRESENTER(S):

Mark P. Joing,
Sr. Director Clinical Operations,
Nora Therapeutics, Inc.

Darlene Panzitta,
President and Founder,
DSP Clinical Research


11:15am – 12:15pm
(TB03) Benchmarking Relationship Quality and Performance with Integrated CRO Partners

MODERATOR:

Boris Reznik, Ph.D., Chairman,
bioRASI, Inc.

PRESENTER(S):

Gen Li, Founder,
PhEsi

Linda Sullivan, VP Operations,
Metrics Champion Consortium

10:15 – 11:15am
(TC02) Clinical Trials Monitoring - Managing Risk and Best Practices

MODERATOR:

David Piatt, CEO,
Medicare Consul Services

PRESENTER(S):
(TC02a) Risk-based Monitoring

Liz Wool, President and CEO,
QD - Quality and Training Solutions, Inc.

(TC02b) Best Practices Ensuring CRA
Performance Quality

Elizabeth Mendes, MPH, Executive Director, Global Study Management, Amgen, Inc.


11:15am – 12:15pm
(TC03) Improving the Informed Consent
Process (Technology and Practices)

MODERATOR:

David Piatt, CEO,
Medicare Consul Services

PRESENTER(S):

Margo Michaels, Executive Director, ENACCT

Lindsay McNair, M.D., MPH, Principal Consultant,
Equipoise Consulting, LLC


12:15 – 1:15 pm
Exhibit Hall CLOSED (for Luncheon - all attendees are invited and welcome to attend Working Luncheon)

Working Luncheon (Plated): Featuring Solution Provider Showcase Presentations

  • 12:15 – 12:45: Appetizer and Main Course Service
  • 12:45 – 12:55 pm
    “Management Approaches and Considerations in Clinical Research”
    Craig A. Serra, Director, Clinical and Strategic Operations,
    DSP Clinical Research

  • 12:55 – 1:05 p.m.
    “Clinical Conductor CTMS: Redefining Research Project Management"
    Sergio Armani, Director, Business Development,
    Bio-Optronics
  • 1:05 – 1:15 p.m.
    “Early Clinical Development Studies"
    Lorraine Rusch, Ph.D., VP,
    Vince & Associates Clinical Research

1:15 – 4:15pm
Exhibit Hall OPEN


1:15 – 1:45pm
DESSERT AND COFFEE BUFFET SERVICE (In Exhibit Hall)


Track A:
Innovative Strategies:
Leadership, Innovations and Global Solutions
Track B:
Operating Practices & Efficiencies:
Real-world case studies and Practical
How-tos for Sponsors, Sites, CROs and everyone in between
Track C:
Effective Oversight & Regulation:
FDA, Medicare, Medicaid, Subject Protection and more
Track Moderator:

Amy Fontaine, Sr. Manager, CenterWatch
Track Moderator:

Darlene Panzitta, President &
Founder, DSP Clinical Research
Track Moderator:

Joan A. Chambers, Chief
Operating Officer, CenterWatch

1:45 – 2:40pm
(TA04) New Strategies with Investigator-initiated Clinical Trials

MODERATOR:

Jeff Rosen, M.D., Medical Director, Clinical Research of South Florida

PRESENTER(S):

Karen Bartels, Clinical Project Manager, Oncology, AstraZeneca

Stephanie Zafonte, MSN, RN, CCRP, Nurse Consultant,
Clinical Project Manager,
NIH/NIAID/DMID/EHDB


2:45 – 3:40pm
(TA05) Predicting Top Performing Investigative Sites

MODERATOR:

Dan Ulrey, President & CEO,
MCSI

PRESENTER(S):

John Humphreys, Senior Product Manager, IMS Health

Fabio Thiers, M.D., Ph.D., CEO, ViS Research Institute

1:45 – 2:40pm
(TB04) The Evolving Role of Transactional
Outsourcing in Clinical Research

MODERATOR:

Boris Reznik, Ph.D., Chairman,
bioRASI, Inc.

PRESENTER(S):

Jacqueline Mardell, President, Anhvita BioPharma Consulting, Inc.

Tom Sellig, Global VP,
Clinical Development Services, Covance, Inc.


2:45 – 3:40pm
(TB05) Assessing the Financial and Operating Health of the Global Site Landscape

MODERATOR:

Jeff Rogers, SVP, Sales and Marketing, Clinverse

PRESENTER(S):

Amanda Wright, VP,
PMG Research, Inc.

Adam Chasse, COO,
RxTrials, Inc.

1:45 – 2:40pm
(TC04) Coordinating Ethical Review among Global Sites

MODERATOR:

Margo Michaels, Executive Director, ENACCT

PRESENTER(S):

Jack Corman, President,
IRB Services

Susan Donahue, VP Compliance and Training, PMG Research, Inc.


2:45 – 3:40pm
(TC05) Best Practices for Selecting and Managing a Central IRB

MODERATOR:

Lindsay McNair, M.D., MPH, Principal Consultant,
Equipoise Consulting, LLC

PRESENTER(S):

Soo Bang, Director, Global Head Site Contracts and CTAs,
Celgene Corporation

Jim Saunders, President,
New England Institutional Review Board


3:45 – 4:15
MID-AFTERNOON NETWORKING BREAK (In Exhibit Hall)


4:15 – 5:45pm
Exhibit Hall CLOSED (for conference sessions)


4:15 – 4:40pm
(TA06) New Strategies to Shorten Development Cycle Time

MODERATOR:

Dan Ulrey, President and CEO,
MCSI

PRESENTER(S):

Lorraine Rusch, Ph.D., VP, Business Development,
Vince & Associates Clinical Research


4:45 – 5:10pm
(TA07) Factors Associated with Higher NME Success Rates

MODERATOR:
Ken Getz, Founder and Owner, CenterWatch; Director, Sponsored Research Programs, Tufts CSDD; Chairman, CISCRP
PRESENTER(S):

Joe DiMasi, Director, Economic Analysis, Tufts Center for the Study of Drug Development


5:15 – 5:45pm
(TA08) Anticipating Mergers and Acquisitions among Sponsors and CROs

MODERATOR:

Joan Chambers, COO,
CenterWatch

PRESENTER(S):

Christopher Codeanne, CFO,
Premier Research

Michael Martorelli, Director,
Fairmount Partners

Penny Smith, Attorney,
Penny Smith Life Science Law Group

Peter Sullivan, CIC, VP and Principal, Sullivan Group

4:15 – 4:40pm
(TB06) Working with Alternative Investigative Site Models

MODERATOR:

Christian Burns, Director of Clinical Operations and Marketing, ClinEdge, LLC

PRESENTER(S):

Terry Stubbs, President and CEO,
ActivMed Practices & Research


4:45 – 5:10pm
(TB07) Reducing the Incidence and Cost of
Protocol Amendments and Extraneous
Protocol Data

MODERATOR:

Randy Krauss, Head Director, Metrics, Analytics and Performance, Sanofi

PRESENTER(S):

Beth Harper, BS, MBA, President,
Clinical Performance Partners, Inc.


5:15 – 5:45pm
(TB08) Technology Solutions Streamlining
Development Activity and Improving
Quality

MODERATOR:

Jane Green, CEO,
Morley Research Consortium, LLC

PRESENTER(S):

Chris Ramm, Global Director, Sales and Marketing, Clinical Ink

4:15 – 4:40pm
(TC06) Anticipating a Shifting Landscape for
Local & Central IRBs and Ethical Review
Committees

MODERATOR:

Stuart Horowitz, President, Institutions & Institutional Services, WIRB-Copernicus Group

PRESENTER(S):

Mohanish Anand, Senior Director, Clinical Trial Support and Compliance, Pfizer


4:45 – 5:10pm
(TC07) IRB Response to Key Changes in Clinical Research Practice

MODERATOR:

Joan Chambers, COO,
CenterWatch

PRESENTER(S):

Cami Gearhart, CEO,
Quorum Review


5:15 – 5:45pm
(TC08) New Technology Solutions Improving Ethical Review Process Impact

MODERATOR:

Jack Corman, President,
IRB Services

PRESENTER(S):

Mitchell Efros, M.D., FACS, CEO,
Verified Clinical Trials

Kerri Weingard, COO,
Verified Clinical Trials


5:45 – 7:15pm
Exhibit Hall OPEN


SPONSORED BY:

5:45 – 7:00pm
GALA EVENING NETWORKING RECEPTION (in Exhibit Hall)

Tuesday, May 21, 2013

8:00 – 9:00am
Exhibit Hall OPEN
Conference Registration and Continental Breakfast (in Exhibition Hall)

9:00 – 10:45am
Exhibit Hall CLOSED (for conference sessions)


9:00 – 9:40am
(TP01) Drug Development Landscape Trends: Trends in Technologies, Regulation, Consolidation and Study Volunteers

Ken Getz, Founder and Owner, CenterWatch
Director, Sponsored Research Programs, Tufts CSDD
Chairman, CISCRP

9:45 – 10:45am
(TP01a) Technologies, Regulations and Study Volunteers: A Moderated Panel Discussion

MODERATOR:  

Ken Getz, Founder and Owner, CenterWatch
Director, Sponsored Research Programs, Tufts CSDD
Chairman, CISCRP

 
PANELISTS:  

Jane Green, CEO,
Morley Research Consortium, LLC

Adrian Otte, VP, Global Development Operations, Amgen, Inc.

Christine Pierre,Founder and President,
Society for Clinical Research Sites

Beat Widler, Ph.D., Managing Partner,
Widler & Scheimann AG


10:30 – 12:00pm
Exhibit Hall OPEN


SPONSORED BY:

10:45 – 11:15am
MID-MORNING NETWORKING BREAK (In Exhibit Hall)


11:15am
CONCURRENT TRACKS BEGIN: Choose from Tracks A, B, or C

Track A:
Innovative Strategies:
Leadership, Innovations and Global Solutions
Track B:
Operating Practices & Efficiencies:
Real-world case studies and Practical
How-tos for Sponsors, Sites, CROs and everyone in between
Track C:
Effective Oversight & Regulation:
FDA, Medicare, Medicaid, Subject Protection and more
(TA09) Track Moderator:

Amy Fontaine, Sr. Manager, Marketing, CenterWatch
(TB09) Track Moderator:

Joan A. Chambers, Chief
Operating Officer, CenterWatch
(TC09) Track Moderator:
Stuart Horowitz, President, Institutions & Institutional Services, WIRB-Copernicus Group

11:15 –11:40am
(TA10) Reaching and Recruiting Diverse Patient Populations

MODERATOR:

Barbara Burkott, RN, BSN, CCRP, Bay State Medical Center

PRESENTER(S):

Kim Ribeiro, Patient Recruitment
Specialist II, Parexel International


11:45am – 12:10pm
(TA11) Direct-to-Patient Recruitment Strategies and Tactics

MODERATOR:

Ashley Tointon, Manager Patient Recruitment Strategy Group, Parexel International

PRESENTER(S):

Gretchen O’Neill, Director of
Operations, Acurian

11:15 –11:40am
(TB10) Sharing Ineligible Patients

MODERATOR:

Bonnie Brescia, Founding Principal, BBK Worldwide

PRESENTER(S):

Lisa La Luna, SVP, Corporate Development& Innovation, ePharmaSolutions


11:45am – 12:10pm
(TB11) Rethinking Compassionate Use Programs

MODERATOR:

Bonnie Brescia, Founding Principal, BBK Worldwide

PRESENTER(S):

Lisa Sanders, Ph.D.,
Senior Clinical Strategy Scientist, Cato Research

11:15 –11:40am
(TC10) Navigating the Medicare Billing Guidelines in the Clinical Trials Realm

MODERATOR:

Stuart Horowitz, President, Institutions & Institutional Services, WIRB-Copernicus Group

PRESENTER(S):

David Piatt, CEO,
Medicare Consul Services


11:45am – 12:10pm
(TC11) Tightening Regulation on KOL Use

MODERATOR:

Stuart Horowitz, President, Institutions & Institutional Services, WIRB-Copernicus Group

PRESENTER(S):

Nick Repucci, Manager,
Dentons


12:15 – 1:15pm
Exhibit Hall CLOSED (for Luncheon - all attendees are invited and welcome to attend Working Luncheon)

WORKING LUNCHEON (PLATED): KEYNOTE PRESENTATION
SPONSORED EXCLUSIVELY BY:

12:45 – 1:15
“Transforming Ethical Review: The Formation of The WIRB-Copernicus Group”

Donald A. Deieso, Ph.D., Operating Partner and Co-Head, Healthcare Group,
Arsenal Capital Partners and Executive Chairman, The WIRB-Copernicus Group


1:15 – 3:30pm
Exhibit Hall OPEN


1:15 – 1:40
DESSERT AND COFFEE BUFFET SERVICE (In Exhibit Hall) SPONSORED EXCLUSIVELY BY:



Track A:
Innovative Strategies:
Leadership, Innovations and Global Solutions
Track B:
Operating Practices & Efficiencies:
Real-world case studies and Practical
How-tos for Sponsors, Sites, CROs and everyone in between
Track C:
Effective Oversight & Regulation:
FDA, Medicare, Medicaid, Subject Protection and more
Track Moderator:

Amy Fontaine, Sr. Manager, Marketing, CenterWatch
Track Moderator:

Joan A. Chambers, Chief
Operating Officer, CenterWatch
(TC09) Track Moderator:
Stuart Horowitz, President, Institutions & Institutional Services, WIRB-Copernicus Group

1:45 – 2:10pm
(TA12) Crowd-Sourcing among Patients to Improve Protocol Feasibility

MODERATOR:

Richard Robinson, Director, Asset Lead-Oncology Development Operations, Pfizer

PRESENTER(S):

Gretchen Goller, MSW, Senior Director, Patient Access & Retention Services, PRA International


2:15 – 2:55pm
(TA13) Assessing the State and Impact of EMR/EHR Adoption and Integration

MODERATOR:

Rick Morrison, CEO,
Comprehend Systems

PRESENTER(S):

Wayne Kubick, CTO,
CDISC

1:45 – 2:10pm
(TB12) Motivating Sites and Patients in Long Duration Clinical Trials

MODERATOR:

Darlene Panzitta, President and Founder, DSP Clinical Research

PRESENTER(S):

Lucas Garmon, Patient Engagement Advisor,
BBK Worldwide


2:15 – 2:55pm
(TB13) Enhanced Compliance and Quality
through Real-time Visibility into Study
Conduct

MODERATOR:

Jane Green, CEO,
Morley Research Consortium, LLC

PRESENTER(S):

Srini Kalluri, Founder, President and CEO, Forte Research Systems, Inc.

1:45 – 2:10pm
(TC12) New Regulations for Communicating Clinical Trial Results to Volunteers and the Public

MODERATOR:

Jim Saunders, President,
New England Institutional Review Board

PRESENTER(S):

Cheryl Dubenezic,
Director, Regulatory Affairs,
Hackensack University Medical Center

 


2:15 – 2:55pm
(TC15) Review and Analysis of Recent Investigative Site Inspection Results

MODERATOR:

Joan Chambers, COO,
CenterWatch

PRESENTER(S):

Robert Romanchuk, Principal,
Clinical Research Advisors, LLC


3:00 – 3:30pm
MID-AFTERNOON NETWORKING BREAK AND ANNOUNCEMENT OF TRIVIAL PURSUIT WINNERS (In Exhibit Hall)


3:30pm
Exhibit Hall CLOSED (for exhibition strike & load-out)


3:30 – 3:55pm
(TA14) Growing Academic Research Center Involvement in Industry-Sponsored Trials

MODERATOR:

Carmela Houston-Henry, MS, CCRA, Director, Corporate Development and Operations Support, Biomedical Research Alliance of New York (BRANY)

PRESENTER(S):

Jean M. Gatewood, Director, Clinical Trials Office, New York University Medical Center


4:00 – 4:30pm
(TA15) Novel Approaches to Selecting and Managing Investigative Sites

MODERATOR:

Richard Robinson, Director, Asset Lead - Oncology Development Operations, Pfizer

PRESENTER(S):

Vicky DiBiaso, Director, Head of
Investigator Networks, Sanofi

3:30 – 3:55pm
(TB14) New Practices to Improve Patient Retention

MODERATOR:

John Needham, President,
Patient Recruitment Strategy, LLC

PRESENTER(S):

Melynda Geurts, MS, VP, Operations, DAC Patient Recruitment Services


4:00 – 4:30pm
(TB15) New Technologies and Solutions Improving Study Conduct Practices: (Start-up, Patient Recruitment and Retention, Payments, and Training Requirements for Site Personnel)

MODERATOR:

Jim DiCesare, Vice President and General Manager, Contract and Regulatory Services, CFS Clinical

PRESENTER(S):

Kevin Williams, MBA/MS, VP, Corporate Development and Marketing, CFS Clinical

Beth Harper, BS, MBA, President,
Clinical Performance Partners, Inc.

3:30 – 3:55pm
(TC14) Rethinking the Investigator Brochure

MODERATOR:

David Reiner, M.D., FACC, Medical Director, Frontage Clinical Research

PRESENTER(S):

Holly Coulter, CEO,
CE3, Inc.



4:30pm
CONFERENCE CONCLUDES

& THANK YOU FOR YOUR DEDICATION TO THE CLINCAL RESEARCH PROFESSION!



Thanks to the following
CLINICAL RESEARCH INDUSTRY LEADERS that have ENDORSED THIS CENTERWATCH CONFERENCE